Major determinants of hyperhomocysteinemia in peritoneal dialysis patients-Reference-Cited by-同舟云学术

Major determinants of hyperhomocysteinemia in peritoneal dialysis patients

Published:1998-06 Issue:6 Volume:53 Page:1775-1782
ISSN:0085-2538
Container-title:Kidney International
language:en
Short-container-title:Kidney International

Author:

Vychytil Andreas,Födinger Manuela,Wölfl Gabriele,Enzenberger Brigitte,Auinger Martin,Prischl Friedrich,Buxbaum Martina,Wiesholzer Martin,Mannhalter Christine,Hörl Walter H.,Sunder-Plassmann Gere

Publisher

Elsevier BV

Subject

Nephrology

Reference39 articles.

1. Hyperhomocysteinemia and the risk for vascular disease in hemodialysis patients;BACHMANN;J Am Soc Nephrol,1995

2. Hyperhomocysteinemia and traditional cardiovascular disease risk factors in end-stage renal disease patients on dialysis: A case-control study;BOSTOM;Atherosclerosis,1995

3. Hyperhomocysteinemia confers an independent increased risk of atherosclerosis in end-stage renal disease and is closely linked to plasma folate and pyridoxine concentrations;ROBINSON;Circulation,1996

4. Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients;BOSTOM;Atherosclerosis,1996

5. Hyperhomocysteinemia, a risk factor for atherosclerosis in chronic uremic patients;CHAUVEAU;Kidney Int,1993

Cited by 77 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Vitamin metabolism and requirements in chronic kidney disease and kidney failure;Nutritional Management of Renal Disease;2022

2. Gut Microbiome, Functional Food, Atherosclerosis, and Vascular Calcifications—Is There a Missing Link?;Microorganisms;2021-09-09

3. Decisive evidence corroborates a null relationship between MTHFR C677T and chronic kidney disease;Medicine;2020-07-17

4. Homocysteine and IgA nephropathy: observational and Mendelian randomization analyses;Chinese Medical Journal;2020-01-07

5. Folic Acid and Vitamin B12 Administration in CKD, Why Not?;Nutrients;2019-02-13